Navigation Links
New Dermatological Formula Targets Psoriasis, Eczema and Other Extreme Skin Conditions
Date:9/13/2011

ORMOND BEACH, Fla., Sept. 13, 2011 /PRNewswire/ -- Florida-based SkinHealth Technology introduces a powerful, breakthrough formula that combines cutting-edge cosmeceutical ingredients -- peptides, polysaccharides and botanical emollients -- with a proven skin protectant to help combat even the most serious skin conditions. ExtremeSkinCare Intense Treatment Balm helps reduce the unsightly appearance of psoriasis, eczema, and rosacea and relieve inflamed and irritated skin without steroids.

Millions of Americans are affected by psoriasis, eczema, rosacea or other troublesome skin conditions, leaving them searching for a safe, effective topical treatment.

Dermatologist Jeffrey Parks, MD and a team of skincare experts have developed a formulation containing a perfect combination of ingredients that help reduce inflammation, redness and clear affected skin of plaques.

ExtremeSkinCare Intense Treatment Balm:

  • Helps reduce inflammation, redness, itching and irritation
  • Protects and relieves dry, cracked and scaling skin
  • Increases skin's resistance to further physical damage by 60%
  • Helps improve skin elasticity and stimulates collagen synthesis

SkinHealth Technology LLC, an R&D based development company which formulates advanced dermatological, therapeutic skincare products, was founded in 2008. Jeffrey Parks, MD and a team of skincare professionals develop effective formulas that address bruising, acne, vitamin D deficiency, sun damage and chronic skin conditions.

For more detailed information about ExtremeSkinCare Intense Treatment Balm or to schedule an interview, please contact Jack Surrette at 386.236.9949 or visit http://www.skinhealthtech.com.

Contact:

Jack Surrette
Executive Director
SkinHealth Technology LLC
P.O. Box 731626, Ormond Beach, FL 32173
386.236.9949 or jes@skinhealthtech.com

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE SkinHealth Technology LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBays Novel Aganocide Drugs for Major Dermatological Conditions
2. Pradaxa® (dabigatran etexilate mesylate) Capsules Now on Formulary at Nations Top Heart Hospitals
3. BioLife Solutions Now The Leading Supplier of Pre-Formulated GMP Cryopreservation Media for Umbilical Cord Blood Stem Cells
4. Cerno Bioscience Introduces MassWorks AutoID for Fully Automated Quadrupole MS Formula Determination
5. Parenteral Depots Offer $8 Billion of Reformulation Opportunities and a Strong Competitive Edge in Crowded Pharmaceutical Space
6. Advanced Life Sciences Submits Full Proposal to NIAID for Development of Intravenous Formulation of Restanza as a Biodefense Countermeasure
7. Kibow Biotech Releases Results of Pilot Scale Study of Its Probiotic Formulation for Kidney Health
8. Australian Patent Issued to CreAgri® for Ultraviolet Radiation (UVR) Protection by its Hydroxytyrosol-Based Formulations
9. Biosynthetic corneas formulated with recombinant collagen restore vision and nerve growth
10. Advanced Life Sciences Announces Successful Preclinical Data Supporting Restanza Intravenous Formulation for Hospital Use
11. Maximize Market Research to Improve Formulary Access Within Managed Markets Sector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... ... 2016 , ... Shimadzu Scientific Instruments will showcase several new ... poster sessions, and present on the analysis of mycotoxins and medical cannabis at ... 10 at the Georgia World Congress Center in Atlanta, Georgia. , Attendees ...
(Date:2/4/2016)... SHENZHEN, China , Feb. 4, 2016 ... government, and various medical institutions attended a ceremony in ... provide integrative, personalized cell therapy in 2016. ... the "Shenzhen Clinical Translation Platform for Personalized Cell Therapy" ... Shenzhen Regional Cell Production Center, both subsidiaries of Beike ...
(Date:2/4/2016)... and MENLO PARK, Calif. , ... DMPI) ("DelMar" and the "Company"), a biopharmaceutical company focused on ... that it will present at the 18 th ... 8, 2016 at 10:00 a.m. EST in New ... DelMar,s president and CEO, will provide an update on the ...
(Date:2/4/2016)... , Feb. 4, 2016 ContraVir Pharmaceuticals, Inc. ... the development and commercialization of targeted antiviral therapies, announced ... Investor Conference 2016, to be held February 8-9, 2016, ... Group,s 2016 Disruptive Growth & Healthcare Conference, taking place ... 10-11, 2016. James Sapirstein , Chief Executive ...
Breaking Biology Technology:
(Date:1/22/2016)... 22, 2016 ... of the  "Global Behavioral Biometric Market ... --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced ... Biometric Market 2016-2020"  report to their ... Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced the ...
(Date:1/20/2016)... , Jan. 20, 2016   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... significant achievements are the result of the company,s laser ... iMedNet eClinical , it,s comprehensive, easy-to-use and highly ... --> Key MedNet growth achievements in 2015 ...
(Date:1/13/2016)... January 13, 2016 --> ... a new market report titled - Biometric Sensors Market - ... 2015 - 2023. According to the report, the global biometric sensors ... anticipated to reach US$1,625.8 mn by 2023, expanding at ... terms of volume, the biometric sensors market is expected ...
Breaking Biology News(10 mins):